<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82800">
  <stage>Registered</stage>
  <submitdate>6/05/2008</submitdate>
  <approvaldate>8/05/2008</approvaldate>
  <actrnumber>ACTRN12608000235303</actrnumber>
  <trial_identification>
    <studytitle>Topical capsaicin in burning mouth syndrome</studytitle>
    <scientifictitle>The efficacy of topical capsaicin in reducing symptoms in patients with burning mouth syndrome</scientifictitle>
    <utrn />
    <trialacronym>BMS capsaicin</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>burning mouth syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will be instructed to apply topical capsaicin 0.075%, twice a day (middle morning and middle afternoon) for 8 weeks with a one-week interval - the fourth.</interventions>
    <comparator>The control group received placebo - the water based cream utilized as vehicle for the capsaicin, twice a day, 4 weeks.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>relief of symptoms assessed through a visual analogue scale and a questionnaire of an overall effect perceived</outcome>
      <timepoint>4 weeks after starting medication or placebo, 8 weeks at the ending of drug administration and 12 weeks, four weeks after drug discontinuation.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>lasting of the benefits achieved - relief of symptoms, measured through visual analogue scale and a questionnaire of an overall effect perceived</outcome>
      <timepoint>six months after discontinuation of drug treatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>burning mouth syndrome, no recent use of other drugs</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>diabetic patients, anemia, candida infection</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>10/12/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Sao Paulo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Sao Paulo University</primarysponsorname>
    <primarysponsoraddress>Prof Lineu Prestes Av, 2227  Sao Paulo
PC 05508-000</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Sao Paulo University</fundingname>
      <fundingaddress>Prof Lineu Prestes Av, 2227  Sao Paulo
PC 05508-000</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)</sponsorname>
      <sponsoraddress>Ministerio da Educacao, anexos I e II, Brasilia, DF, PC 70359-970</sponsoraddress>
      <sponsorcountry>Brazil</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sao Paulo University, School of Dentistry Ethics Committee</ethicname>
      <ethicaddress>Prof Lineu Prestes Av, 2227  Sao Paulo
PC 05508-000</ethicaddress>
      <ethicapprovaldate>10/08/2007</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>bianca fréo</name>
      <address>Prof Lineu Prestes Av, 2227  Sao Paulo
PC 05508-000</address>
      <phone>55 11 98908221</phone>
      <fax />
      <email>bifreo@usp.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>norberto nobuo sugaya</name>
      <address>Prof Lineu Prestes Av, 2227  Sao Paulo
PC 05508-000</address>
      <phone>55 11 30917883</phone>
      <fax>55 11 30917883</fax>
      <email>nnsugaya@usp.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>bianca fréo</name>
      <address>Prof Lineu Prestes Av, 2227  Sao Paulo
PC 05508-000</address>
      <phone>55 11 98908221</phone>
      <fax />
      <email>bifreo@usp.br</email>
      <country>Brazil</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>